2010
ReadCapri S, Benucci M, Iannazzo S, Zaniolo O, D’Arpino A. Un modello di Budget Impact per la valutazione economica di tocilizumab come prima linea biologica nei pazienti con artrite reumatoide di grado moderato o severo. Italian Journal of Public Health – Year 8, Volume 7, Number 2, Suppl 2, 2010: S44-53 ReadEandi M, Pradelli L, Iannazzo S, Chiroli S, Pontoriero G. Economic evaluation of cinacalcet in the treatment of...
2010
Valutazione farmacoeconomica dell’uso di tiotropio bromide nel trattamento di lungo termine dei pazienti con BPCO in Italia. 15° Convegno Annuale AIES, Turin, Italy, 1st October, 2010 Amgen Advisory Board: Relationship Between Vascular Calcification and Clinical and Health Economics Outcomes in Dialysis Patients. Zurich, Switzerland, 18th June, 2010 L’importanza dell’adiuvante MF59 nei vaccini influenzali: aggiornamento su sicurezza, efficacia clinica e dati di farmacoeconomia. Congress SItI, Turin, Italy, 25th May, 2010 and Naples, Italy,...
2010
Zaniolo O, Pradelli L. Economic Performance of Dabigatran Etexilate for Primary VTE Prevention Following Total Hip and Knee Replacement Surgery in Italy. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010 Iannazzo S, Pradelli L, Chiroli S. A Cost-Utility Analysis of Cinacalcet in Secondary Hyperparathyroidism (SHPT) in Five European Countries. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010 Iannazzo S, Zaniolo O, Giuliani G....
